Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.6M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
22.6M
-
Shares change
-
-1.04M
-
Total reported value, excl. options
-
$38.4M
-
Value change
-
-$6.72M
-
Number of buys
-
28
-
Number of sells
-
-21
-
Price
-
$1.70
Significant Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q4 2024
61 filings reported holding VIGL - Vigil Neuroscience, Inc. - Common Stock as of Q4 2024.
Vigil Neuroscience, Inc. - Common Stock (VIGL) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.6M shares
of 46.6M outstanding shares and own 48.49% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5.84M shares), Siren, L.L.C. (1.99M shares), BVF INC/IL (1.81M shares), CITADEL ADVISORS LLC (1.51M shares), SPHERA FUNDS MANAGEMENT LTD. (1.5M shares), 683 Capital Management, LLC (1.4M shares), VANGUARD GROUP INC (975K shares), Ensign Peak Advisors, Inc (703K shares), Pivotal bioVenture Partners Investment Advisor LLC (561K shares), and abrdn plc (528K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.